Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026)
Inogen (INGN) reported Non-Current Deffered Revenue of $3.2 million for Q1 2026, down 37.93% year-over-year from $5.1 million in Q1 2025, and down 12.02% quarter-over-quarter from $3.6 million in Q4 2025.
Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Non-Current Deffered Revenue data on file, last reported at $3.2 million in Q1 2026.
- Non-Current Deffered Revenue for Q1 2026 came in at $3.2 million, down 37.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (down 37.93% YoY), and the FY2025 annual result was $3.6 million, down 37.31% from the prior year.
- Non-Current Deffered Revenue fell to $3.2 million in Q1 2026 per INGN's latest filing, from $3.6 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $11.5 million in Q1 2022 and troughed at $3.2 million in Q1 2026.
- A 5-year average of $7.5 million and a median of $7.6 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2022 and 2026: Non-Current Deffered Revenue fell 2.81% in 2022, then slumped 37.93% in 2026.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $10.4 million in 2022, then decreased by 20.89% to $8.2 million in 2023, then tumbled by 30.14% to $5.7 million in 2024, then sank by 37.31% to $3.6 million in 2025, then dropped by 12.02% to $3.2 million in 2026.
- Business Quant data shows INGN's Non-Current Deffered Revenue at $3.2 million in Q1 2026, $3.6 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 8.23 Mn |
| Sep 30, 2023 | 8.88 Mn |
| Jun 30, 2023 | 9.35 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Sep 30, 2022 | 11.03 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 11.51 Mn |
| Dec 31, 2021 | 11.86 Mn |
| Sep 30, 2021 | 12.14 Mn |
| Jun 30, 2021 | 12.19 Mn |